Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
12.33
+0.92 (8.06%)
At close: Dec 15, 2025, 4:00 PM EST
12.20
-0.13 (-1.05%)
After-hours: Dec 15, 2025, 7:28 PM EST
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$876,556
Profits / Employee
$84,333
Market Cap
647.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | 2,200 | 366 | 19.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EBS News
- 3 days ago - Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site - GlobeNewsWire
- 27 days ago - Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions: Solid Q3, Expecting Better Days To Come - Seeking Alpha
- 6 weeks ago - Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Emergent BioSolutions Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness - GlobeNewsWire
- 2 months ago - Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - GlobeNewsWire